| __timestamp | BioCryst Pharmaceuticals, Inc. | Biogen Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 7461000 | 2232342000 |
| Thursday, January 1, 2015 | 13047000 | 2113100000 |
| Friday, January 1, 2016 | 11253000 | 1947900000 |
| Sunday, January 1, 2017 | 13933000 | 1935500000 |
| Monday, January 1, 2018 | 29514000 | 2106300000 |
| Tuesday, January 1, 2019 | 37121000 | 2374700000 |
| Wednesday, January 1, 2020 | 67929000 | 2504500000 |
| Friday, January 1, 2021 | 118818000 | 2674300000 |
| Saturday, January 1, 2022 | 159371000 | 2403600000 |
| Sunday, January 1, 2023 | 213894000 | 2549700000 |
| Monday, January 1, 2024 | 2403700000 |
Unveiling the hidden dimensions of data
In the competitive landscape of biotechnology, understanding the financial strategies of industry leaders is crucial. Over the past decade, Biogen Inc. and BioCryst Pharmaceuticals, Inc. have demonstrated contrasting approaches to their Selling, General, and Administrative (SG&A) expenses. From 2014 to 2023, Biogen's SG&A expenses have consistently been over 30 times higher than those of BioCryst, reflecting its expansive operational scale. Notably, Biogen's spending peaked in 2021, reaching nearly 2.7 billion dollars, while BioCryst's expenses have shown a remarkable growth trajectory, increasing by over 2,700% from 2014 to 2023. This surge highlights BioCryst's aggressive expansion and investment in administrative capabilities. As the biotech sector continues to evolve, these spending patterns offer valuable insights into the strategic priorities and growth potential of these two influential companies.
Breaking Down SG&A Expenses: Johnson & Johnson vs Biogen Inc.
Alnylam Pharmaceuticals, Inc. or Biogen Inc.: Who Manages SG&A Costs Better?
Who Optimizes SG&A Costs Better? Biogen Inc. or Exelixis, Inc.
Comparing SG&A Expenses: Biogen Inc. vs Alpine Immune Sciences, Inc. Trends and Insights
Operational Costs Compared: SG&A Analysis of Biogen Inc. and Xenon Pharmaceuticals Inc.
Biogen Inc. vs Catalyst Pharmaceuticals, Inc.: SG&A Expense Trends
Selling, General, and Administrative Costs: Biogen Inc. vs Dynavax Technologies Corporation
Comparing SG&A Expenses: United Therapeutics Corporation vs BioCryst Pharmaceuticals, Inc. Trends and Insights
Breaking Down SG&A Expenses: Incyte Corporation vs BioCryst Pharmaceuticals, Inc.
Ligand Pharmaceuticals Incorporated or BioCryst Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Breaking Down SG&A Expenses: Amphastar Pharmaceuticals, Inc. vs BioCryst Pharmaceuticals, Inc.
BioCryst Pharmaceuticals, Inc. vs MiMedx Group, Inc.: SG&A Expense Trends